Resorbable Pouches for Cardiac Devices
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for reducing bacterial contamination and infection risks during and after the implantation of cardiac rhythm management devices (CRMs) and other implantable medical devices (IMDs) are inadequate, as existing antimicrobial coatings on devices have shown limited effectiveness in preventing device-related infections and complications such as scarring and fibrosis.
Innovation Solution
Development of biodegradable and resorbable polymer pouches that encapsulate or surround IMDs, incorporating antimicrobial agents like rifampin and minocycline, which are released to prevent bacterial colonization and reduce surgical site infections, while also providing pain relief and preventing scarring or fibrosis through controlled drug elution profiles.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If antimicrobial coatings are applied to IMD surfaces, then bacterial colonization is reduced, but infection prevention effectiveness is insufficient
Solution Approach 1:
A biodegradable polymer pouch is introduced as an intermediary component between the IMD and the body. This pouch encapsulates the device and releases antimicrobial agents (rifampin and minocycline) continuously, creating a protective barrier that effectively prevents bacterial colonization while reducing infection risk.
Solution Approach 2:
Antimicrobial agents are incorporated into the polymer pouch before implantation. The pouch is designed to release these agents proactively during the critical healing period, preventing bacterial colonization before infections can develop, rather than relying on passive surface coatings.
2Object-generated harmful factors
If surface antimicrobial coatings are used, then device colonization is reduced, but surgical site infection prevention is inadequate
Solution Approach 1:
The polymer pouch serves as a mediator that extends the protective effect beyond the device surface. It encapsulates the IMD and releases antimicrobial agents into the surrounding tissue, creating a broad-spectrum protective barrier that addresses both device colonization and surgical site infection risks.
Solution Approach 2:
The protection is extended from a two-dimensional surface coating to a three-dimensional encapsulating pouch structure. This pouch releases antimicrobial agents radially in all directions, providing comprehensive protection around the entire device and at the surgical site.
3Strength
If non-resorbable meshes are used, then structural support is provided, but future removal procedures become complicated
Solution Approach 1:
The polymer pouch is designed to be fully resorbable, automatically discarding itself after serving its protective function during the healing period. This eliminates the need for complex removal procedures later, as the pouch naturally degrades and is absorbed by the body, leaving no foreign material to remove.
Solution Approach 2:
The pouch transitions from a static structural support element to a dynamic, time-dependent component. It provides mechanical support during the critical healing phase, then naturally degrades and is absorbed, adapting its presence over time to match the healing requirements.
4Device complexity
If conventional pouches without drug delivery are used, then simple construction is maintained, but pain relief and fibrosis prevention are insufficient
Solution Approach 1:
Multiple therapeutic functions are merged into a single polymer pouch component. The pouch simultaneously provides mechanical encapsulation, releases antimicrobial agents to prevent infection, delivers analgesics for pain relief, and releases anti-fibrotic agents to prevent scarring, all through one integrated device.
Solution Approach 2:
The polymer pouch is designed as a multi-functional device that performs several roles: structural encapsulation, antimicrobial protection, pain management, and fibrosis prevention. This universal approach eliminates the need for multiple separate components or procedures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The biodegradable polymer pouches effectively reduce bacterial growth and infection risks by delivering antimicrobial agents to the implant site, providing prolonged pain relief and preventing scarring or fibrosis, thus enhancing the safety and efficacy of IMD implantation and future removal procedures.
Implementation Method 1
The pouches can deliver drugs from one or more independent layers... capable of releasing one or more drugs into surrounding bodily tissue and proximal to the device such that the drug reduces or prevents implant- or surgery-related complications
Implementation Method 2
Biodegradable and resorbable polymer pouches are described for use with cardiac rhythm management devices... a pouch, covering, or other receptacle capable of encasing, surrounding and/or holding the CRM or other IMD
Data Source
AI summary
Biodegradable and resorbable polymer pouches are described for use with cardiac rhythm management devices (CRMs) and other implantable medical devices (IMDs), i.e., a pouch, covering, or other receptacle capable of encasing, surrounding and/or holding the CRM or other IMD for the purpose of securing it in position, inhibiting or reducing bacterial growth, providing pain relief and/or inhibiting scarring or fibrosis on or around the CRM or other IMD. Optionally, the biodegradable and resorbable pouches of the invention include one or more drugs in the polymer matrix to provide prophylactic effects and alleviate side effects or complications associated with the surgery or implantation of the CRM or other IMD.